Connection
Eliza Kramer to Lung Diseases
This is a "connection" page, showing publications Eliza Kramer has written about Lung Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.246 |
|
|
|
-
Kramer EL, Hardie WD, Mushaben EM, Acciani TH, Pastura PA, Korfhagen TR, Hershey GK, Whitsett JA, Le Cras TD. Rapamycin decreases airway remodeling and hyperreactivity in a transgenic model of noninflammatory lung disease. J Appl Physiol (1985). 2011 Dec; 111(6):1760-7.
Score: 0.214
-
Peterson CJ, Rao MB, Palipana A, Manning ER, Vancil A, Ryan P, Brokamp C, Kramer E, Szczesniak RD, Gecili E. Robust identification of environmental exposures and community characteristics predictive of rapid lung disease progression. Sci Total Environ. 2024 Nov 10; 950:175348.
Score: 0.033